Related Experiment Video
Updated: Aug 6, 2026
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Why is cardiovascular health important in menopausal women?
1Department of Pharmacology, Saint Antoine University Hospital, Paris, France.
Insights
Cardiovascular disease (CVD) is a leading cause of death in women post-menopause. Increased awareness, research inclusion, and tailored prevention strategies are crucial for women
Area of Science:
- Cardiovascular Medicine
- Women's Health
- Endocrinology
Background:
- Cardiovascular disease (CVD) is often misperceived as a male condition due to estrogen's protective effects in premenopausal women.
- Post-menopause, estrogen decline exacerbates cardiovascular risk and metabolic dysfunction in women.
- Low awareness of CVD risk among women and healthcare providers necessitates urgent attention.
Purpose of the Study:
- To highlight the significant burden of CVD in women, particularly after menopause.
- To address the under-representation of women in clinical studies and the implications for treatment.
- To advocate for improved CVD risk detection, management, and prevention in women.
Main Methods:
- Review of existing literature on gender differences in cardiovascular disease.
- Analysis of the impact of estrogen withdrawal on cardiovascular physiology and metabolism.
- Examination of clinical trial data regarding female participation and outcomes.
Main Results:
- CVD is the primary cause of mortality in women, especially after menopause.
- Women face diagnostic and prognostic disparities compared to men in CVD.
- Gender-specific responses to pharmacological interventions indicate a need for tailored therapies.
Conclusions:
- Equitable diagnostic and treatment standards for women with CVD are essential.
- Increased inclusion of women in clinical trials is vital for developing effective, sex-specific therapies.
- Preventive strategies, including lifestyle modifications, are paramount for mitigating CVD risk in women.
Abstract:
Since endogenous estrogen shows some preventative benefits against cardiovascular risk factors in premenopausal women, cardiovascular disease (CVD) is often considered a male disease. However, CVD is the biggest cause of death in women, especially after menopause when endogenous estrogen withdrawal has detrimental effects on cardiovascular physiology and whole-body metabolism. Despite this, awareness of the risk of CVD is low in both women and in doctors; this needs rectifying. Women are under-represented in most clinical studies of CVD. Following diagnosis of CVD, the prognosis for women is not systematically similar to that for men. Furthermore, from the few comparisons conducted, gender differences in response to pharmacological interventions are evident, so that results obtained in wholly or largely male-based studies cannot be systematically extrapolated to women. Women with CVD should be afforded equivalent investigations and treatment to men, and it is vital that women be included in clinical trials in sufficient numbers to allow sub-group analyses and subsequent development of appropriate therapies. Since CVD is usually advanced by the time symptoms appear, prevention is the key; health management advice might include smoking cessation, adoption of a healthy diet, and incorporation of physical activity into the lifestyle.
More Related Videos
14:26A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
Published on: April 7, 2014
06:04Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
Published on: September 27, 2024
Related Concept Videos
01:28Menopause
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:27Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
01:22Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
01:20Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
01:26Atherosclerosis III: Management